{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:03:25Z","timestamp":1791655405569,"version":"4.3.4"},"reference-count":22,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012833","name":"Niigata University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012833","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: The high risk of CNS dissemination poses a significant challenge in the management of primary vitreoretinal lymphoma (PVRL). We evaluated the clinical value of our institutional protocol for PVRL, which combines targeted vitreous sampling with routine central nervous system (CNS) surveillance using magnetic resonance imaging (MRI) every 4\u20136 months. Methods: We retrospectively reviewed 34 consecutive patients who underwent vitreous biopsies at Niigata University Hospital between January 2010 and December 2021; 12 patients were initially diagnosed with PVRL without CNS involvement. The protocol mandates submission of both undiluted vitreous samples and the entire vitreous cassette contents, including perfusion fluid, for cytologic evaluation. Patients with PVRL underwent MRI surveillance every 4\u20136 months. Results: Among 12 patients with PVRL, vitreous cytology classified as Class IV or higher demonstrated a positivity rate of 75% (9\/12) using undiluted samples alone, which increased to 92% (11\/12) when cassette contents were included. Ancillary test results revealed an interleukin (IL)-10\/IL-6 ratio &gt; 1 in 75% (9\/12) and immunoglobulin heavy chain gene rearrangement in 92% (11\/12). Extraocular relapse occurred in 92% of patients (11\/12), including 10 cases of CNS involvement and one systemic relapse, with a mean time to CNS progression of 11.8 months. The 5-year overall survival was 58%. Conclusions: Comprehensive vitreous sampling incorporating perfusion fluid may improve cytologic detection in PVRL within a single-center setting. Routine MRI surveillance facilitates early detection of CNS relapse in patients with PVRL; however, a survival benefit cannot be established from this retrospective analysis.<\/jats:p>","DOI":"10.3390\/jcm15062344","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:54:37Z","timestamp":1773910477000},"page":"2344","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Vitreous Biopsy and Clinical Course in Vitreoretinal Lymphoma: A Single-Center Retrospective Analysis"],"prefix":"10.3390","volume":"15","author":[{"given":"Naoya","family":"Shiozaki","sequence":"first","affiliation":[{"name":"Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-8808","authenticated-orcid":false,"given":"Tadamichi","family":"Akagi","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-1538","authenticated-orcid":false,"given":"Hiroko","family":"Terashima","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Ando","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2771-4367","authenticated-orcid":false,"given":"Eriko","family":"Ueda","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigo","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Nozaki","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ominato","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaophthalmol.2013.569","article-title":"Vitreoretinal lymphoma: A 20-year review of incidence, clinical and cytologic features, treatment, and outcomes","volume":"131","author":"Levasseur","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0301-4738.156903","article-title":"Primary vitreoretinal lymphom","volume":"63","author":"Mulay","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1002\/cam4.5609","article-title":"Long-term outcomes of combined intravitreal and high-dose systemic methotrexate in VRL","volume":"12","author":"Cheng","year":"2023","journal-title":"Cancer Med."},{"key":"ref_4","unstructured":"International Vitreoretinal B-Cell Lymphoma Registry Investigator Group (2024). Presentation, diagnostic testing and initial treatment of vitreoretinal lymphoma. Ophthalmol. Retina, 7, 32\u201339."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tsubota, K., Usui, Y., and Goto, H. (2020). Identification of prognostic markers in primary vitreoretinal lymphoma by clustering analysis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072298"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40942-021-00346-0","article-title":"Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma","volume":"7","author":"Anthony","year":"2021","journal-title":"Int. J. Retin. Vitr."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gao, J., Peng, X., and Wang, L. (2023). Efficacy and safety of first-line combination therapy vs monotherapy for vitreoretinal lymphoma: A meta-analysis. BMC Ophthalmol., 23.","DOI":"10.1186\/s12886-023-03226-3"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bjh.14848","article-title":"Combined intravitreal methotrexate and systemic chemotherapy followed by reduced-dose whole-brain radiotherapy for primary intraocular lymphoma","volume":"179","author":"Kaburaki","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.survophthal.2023.12.001","article-title":"Diagnostic methods for primary vitreoretinal lymphoma: A systematic review","volume":"69","author":"Huang","year":"2024","journal-title":"Surv. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cca.2020.12.035","article-title":"The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma","volume":"515","author":"Chen","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/IAE.0000000000001922","article-title":"Use of interleukin-10 and IL-10\/IL-6 ratio in ocular samples for screening of vitreoretinal lymphoma","volume":"38","author":"Bienvenu","year":"2018","journal-title":"Retina"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jamaophthalmol.2014.4755","article-title":"Treatment strategies in primary vitreoretinal lymphoma: A 17-center European collaborative study","volume":"133","author":"Riemens","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.21873\/cdp.10010","article-title":"Clinical features of primary vitreoretinal lymphoma: A single-center study","volume":"1","author":"Kase","year":"2021","journal-title":"Cancer Diagn. Progn."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/01.wnl.0000327672.04729.8c","article-title":"Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report","volume":"71","author":"Grimm","year":"2008","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1080\/09273948.2021.1873394","article-title":"More accurate diagnosis of vitreoretinal lymphoma using a combination of diagnostic test results: A Prospective Observational Study","volume":"30","author":"Tanaka","year":"2022","journal-title":"Ocul. Immunol. Inflam."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.3390\/ijms12095684","article-title":"Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma","volume":"12","author":"Wang","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0161-6420(93)31469-7","article-title":"Intraocular lymphoma: Clinical and histopathologic diagnosis","volume":"100","author":"Whitcup","year":"1993","journal-title":"Ophthalmology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10384-023-00997-6","article-title":"Diagnosis and management of vitreoretinal lymphoma: Present and future treatment perspectives","volume":"67","author":"Kaburaki","year":"2023","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00417-019-04266-6","article-title":"Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma","volume":"257","author":"Ito","year":"2019","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13000-016-0479-1","article-title":"Diagnostic efficacy of cell block method for vitreoretinal lymphoma","volume":"11","author":"Kase","year":"2021","journal-title":"Diagn. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"van Rooij, J.L.M., Tokarska, K.A., Ten Dam-van Loon, N.H., Wessels, P.H., Seute, T., Minnema, M.C., and Snijders, T.J. (2022). Central nervous system progression in primary vitreoretinal lymphoma with bilateral and unilateral involvement: A systematic review and meta-analysis. Cancers, 14.","DOI":"10.3390\/cancers14122967"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10384-025-01310-3","article-title":"Recent advances in the diagnosis and treatment of refractory ocular inflammatory diseases: Focus on uveitic macular edema, acute retinal necrosis, and vitreoretinal lymphoma","volume":"70","author":"Takeda","year":"2026","journal-title":"Jpn. J. Ophthalmol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2344\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:21:04Z","timestamp":1774070464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15062344"],"URL":"https:\/\/doi.org\/10.3390\/jcm15062344","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}